29 April 2023 : Database Analysis
Clinical Course of 53 Previously Vaccinated Patients Admitted to the National Hospital in Warsaw, Poland with COVID-19 Between November 2021 and March 2022
Artur Zaczyński1AB, Michał Hampel1AB, Paweł Piątkiewicz2AB*, Jacek Nasiłowski3AB, Sławomir Butkiewicz2AB, Urszula Religioni4DEF, Agnieszka Barańska5CD, Maria Malm
5CD, Agnieszka Neumann-Podczaska 6DEF, Regis Vaillancourt2ACDF, Piotr Merks2AFG
DOI: 10.12659/MSM.939841
Med Sci Monit 2023; 29:e939841
Table 2 Data on vaccinations.
| Characteristic | N | N=53 |
|---|---|---|
| 53 | ||
| Astra | 17 (32.1%) | |
| Johnson | 9 (17.0%) | |
| Moderna | 4 (7.5%) | |
| Pfizer | 23 (43.4%) | |
| 53 | ||
| 1 | 13 (24.5%) | |
| 2 | 39 (73.6%) | |
| 3 | 1 (1.9%) | |
| 53 | ||
| Yes | 49 (92.5%) | |
| No | 4 (7.5%) | |
| 53 | ||
| Median [IQR] | 23.71 [19.86, 26.29] | |
| Range | 0.6, 38.0 | |
| IQR – interquartile range. | ||